BARCLAYS PLC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 56 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 2.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$14,00031,948
+2296.7%
0.00%
Q4 2016$0
-100.0%
1,333
+439.7%
0.00%
Q3 2016$1,000
-50.0%
247
-55.3%
0.00%
Q2 2016$2,000
-98.3%
552
-98.6%
0.00%
Q1 2016$115,000
-14.8%
38,452
+14.1%
0.00%
Q4 2015$135,000
-25.4%
33,713
+11.6%
0.00%
Q3 2015$181,000
+3520.0%
30,207
+4309.8%
0.00%
Q2 2015$5,0006850.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,431,196$2,748,0001.18%
Abingworth LLP 437,994$832,0000.50%
Broadfin Capital, LLC 1,301,622$2,499,0000.26%
Rhenman & Partners Asset Management AB 400,000$768,0000.22%
BVF INC/IL 559,624$1,074,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$3,248,0000.12%
Perceptive Advisors 478,456$919,0000.10%
Gruss Capital Management LP 1,720,000$3,302,0000.08%
SECTORAL ASSET MANAGEMENT INC 247,961$476,0000.02%
Spark Investment Management LLC 36,400$69,0000.01%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders